NEW YORK (TheStreet) -- CHANGE IN RATINGS
Buffalo Wild Wings (BWLD) downgraded at Miller Tabak from Buy to Hold. Valuation call, based on a $148 price target.
Cardinal Health (CAH) upgraded at Sterne Agee to Buy from Neutral. $73 price target. Should deliver superior EPS growth relative to the S&P 500.
Endo Health (ENDP) upgraded at Needham to Underperform to Hold, Needham said. Valuation call.
Endo Health upgraded at Cantor to Hold. $54 price target. Company boosted guidance, but appears fully valued.
Expeditors (EXPD) downgraded at Goldman from Buy to Neutral. $45 price target. Company is sacrificing price to maintain market share.
Halcon (HK) downgraded at Canaccord from Buy to Hold. Valuation call, based on a $6 price target.
Office Depot (ODP) upgraded at B. Riley from Neutral to Buy. Sales have stabilized and the company is keeping a tight lid on costs.
Pioneer Natural Resources (PXD) downgraded at Sterne Agee to Neutral from Buy. Weakening earnings growth outlook.
Red Robin (RRGB) downgraded at BofA/Merrill from Neutral to Underperform, Bank of America/Merrill Lynch said. Valuation call, based on an $80 price target.
Southern Copper (SCCO)upgraded at Cowen to Market Perform. $30 price target. Company is looking to cut costs.
T-Mobile (TMUS)upgraded at Canaccord to Buy. $33 price target. Company is seeing higher subscriber growth.
Stock Comments / EPS Changes
AOL (AOL) raises estimates, price target at UBS. AOL lifted its numbers, UBS said. Driven by strong top-line growth and improving bottom-line. $48 price target and Buy rating.
JAZZ (JAZZ) raises estimates, price target at UBS. Estimates lifted across the board. Lower spend drove earnings upside, given the solid base business and expected business development. $110 price target and Buy rating.
Regeneron (REGN) lifts price target, estimates at UBS. Large upside in DME market and strong Eylea sales. $310 price target and Neutral rating.
SandRidge Energy (SD) lifts estimates, price target at UBS. Lower unit costs and higher than expected gas production. $6.50 price target and Neutral rating.
Tesla (TSLA) estimates, target reduced at Wedbush. Shares of TSLA now seen reaching $205, according to Wedbush. Estimates also cut, given the company's new guidance. Outperform rating.
To submit a news tip, email: email@example.com.